BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
Credit Suisse maintains outperform on Dr Reddy's Lab
Clarity on lesser-known areas of DRL led to correction. Capex should normalise in FY16. US sales in Q4 declined due to high inventory. There has been no price erosion in the US.